Hu et al. explored a method of improving the efficacy of chimeric antigen receptor (CAR) T cells in an immunosuppressive tumor microenvironment by disrupting the programmed cell death protein 1 (PD-1) gene using CRISPR/Cas9-mediated genome editing [167]. Here, PDCD1 is linked to neoplasm.